About

Publications While At HealthPartners

selected publications

Journal Article

Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(®) 5 Automated Insulin Delivery System. 

Diabetes Technology & Therapeutics. 2024

Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. 

Diabetes, Obesity & Metabolism. 2024

Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 

Diabetes Technology & Therapeutics. 2024

Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 

Endocrine Reviews. 2023

Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. 

Diabetes Technology & Therapeutics. 2023

Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes. 

Diabetes Technology & Therapeutics. 2023

Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial. 

Diabetes care. 2022

First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. 

Diabetes Technology & Therapeutics. 2021

Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 

Diabetes care. 2021

Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. 

Diabetes Technology & Therapeutics. 2017

Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. 

JAMA. 2016

Conference Poster

Increased HbA1c variability may shorten time to microalbuminuria development in type 1 diabetes (T1D) [poster]

2018

Review

Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study [review]. 

Diabetes Technology & Therapeutics. 2024

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 

The lancet. Diabetes & endocrinology. 2023

Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 

Diabetes care. 2019

Abstract

First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract]. 

Diabetes. 2020

Contact

full name

B. A. Buckingham

Quick Info

 

Collaboration

Co-author network

Map of science